Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as Having CDK Pathway Alteration
Conditions: Chondrosarcoma; Osteosarcoma; Soft Tissue Sarcoma Intervention: Drug: Abemaciclib Sponsor: Medical College of Wisconsin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2019 Category: Research Source Type: clinical trials
